Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

(1,408)(1,413)Deferred revenue

(83,107)(2,722)Other liabilities

(2,049)(2,823)Net cash used in operating activities

$ (76,278)$   (90,453)Cash flows from investing activities:Purchases of investments

(315,160)(298,054)Sales of investments

10,29011,923Maturities of investments

360,906266,202Transaction costs from Novartis pulmonary asset sale

-(4,440)Purchases of property and equipment

(22,160)(10,763)Net cash provided by investing activities

$  33,876$   (35,132)Cash flows from financing activities:Payments of loan and capital lease obligations

(1,119)(935)Proceeds from issuances of common stock

7,1423,821Net cash provided by financing activities

$
,023$
2,886Effect of exchange rates on cash and cash equivalents

(312)(108)Net decrease in cash and cash equivalents

$ (36,691)$ (122,807)Cash and cash equivalents at beginning of period

49,597155,584Cash and cash equivalents at end of period

$  12,906$
32,777
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
(Date:1/14/2014)... NineSigma , Inc., the leading innovation partner to organizations ... May 14-16, 2014 at the Global Center for Health ... This is the premier industry event for ... open innovation. Participants will learn how world-changing innovation is ...
(Date:1/14/2014)... , January 14, 2014 Equashield ... for hazardous drugs, today announced that it has ... straight year.   Equashield,s closed systems ... pharmacists, nurses and other medical professionals who prepare ...
Breaking Medicine Technology:Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2
... NEW YORK, Jan. 11, 2011 Reportlinker.com announces ... in its catalogue: Innovative Drug ... http://www.reportlinker.com/p0359990/Innovative-Drug-Discovery-in-Emerging-Markets.html Introduction Emerging markets ... pharmaceutical industry, but it has been unclear the ...
... (Nasdaq: STXS ) announces the first successful ... as the company received CE Mark for this latest ... with the Vdrive system, Tamas Szili-Torok, MD, Ph.D., from ... Center in The Netherlands, successfully treated atrial fibrillation in ...
Cached Medicine Technology:Reportlinker Adds Innovative Drug Discovery in Emerging Markets 2Reportlinker Adds Innovative Drug Discovery in Emerging Markets 3Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 2Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 3
(Date:4/23/2014)... investigators may lead to greater availability and acceptability of ... use of fecal material from healthy donors to treat ... ( C. difficile ) bacteria. In their paper ... Diseases , the researchers report that use of prescreened ... as successful in curing recurrent C. difficile ...
(Date:4/23/2014)... 24, 2014 Pregnant immigrants from Sub-Saharan Africa, ... monitoring during pregnancy, according to new research from ... in the British Journal of Obstetrics and ... eclampsia rates among immigrants and native-born women in ... Denmark, Sweden, Spain (Catalonia and Valencia) and the ...
(Date:4/23/2014)... at Washington State University Spokane have developed a ... to nod off behind the wheel. , Their ... movementswhich are more variable in drowsy driversand offers ... available video-based driver drowsiness detection systems. , Van ... a car is drifting out of its lane ...
(Date:4/23/2014)... researcher is looking to give exercise enthusiasts the extra ... research shows that a cyber buddy can help. , ... Health Journal , is the first to indicate that ... during exercise, a software-generated partner also can be effective. ... real can still motivate people to give greater effort ...
(Date:4/23/2014)... high-energy particles, simulating conditions astronauts would face on a ... slower reaction times, even when the radiation exposure is ... which affected a large subset, but far from ... to protein changes in the brain, the scientists say. ... suggest it may be possible to develop a biological ...
Breaking Medicine News(10 mins):Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:WSU innovation improves drowsy driver detection 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
... , SUNNYVALE, Calif., July 7 Pharmacyclics, Inc. (Nasdaq: ... close of trading on July 15, 2009 as the record ... rights offering, shares of Pharmacyclics would have to be purchased ... settlement period. , , The rights offering will be ...
... Uganda and NAIROBI, Kenya and DELHI, India, July 7 ... International Treatment Preparedness Coalition (ITPC) calls on leaders of the ... that AIDS treatment and prevention programs for millions of men, ... economic down-turn. , , "Cutting funds for HIV ...
... at birth are the leading cause of heart failure ... United States have structural heart problems ranging in severity ... chambers of the heart, to very severe malformations, including ... The July issue of the journal Pediatric ...
... (Boston) Researchers from Boston University School of Medicine ... treatment option for treating esthesioneuroblastoma (cancer of the nasal ... treatments. These findings appear in the July issue of ... that develops in the upper part of the nasal ...
... ... manufacturer of the permanent makeup worn by the late Michael Jackson, are speaking out against ... ... Hammons , celebrity permanent makeup artist and her company, Premier Pigments , the manufacturer ...
... inc. (OTC Bulletin Board: CLAI), a leading provider of ... industry, announced today that a well established Health Care ... elected to use Claimsnet,s system and services. , ... claims administration and cost containment services in the international ...
Cached Medicine News:Health News:Pharmacyclics Sets Record Date for Rights Offering 2Health News:Pharmacyclics Sets Record Date for Rights Offering 3Health News:World Financial Crisis and AIDS Backlash Threaten Lives 2Health News:World Financial Crisis and AIDS Backlash Threaten Lives 3Health News:New strategies to improve treatment and ultimately prevent heart failure in children 2Health News:New strategies to improve treatment and ultimately prevent heart failure in children 3Health News:Study shows endoscopic surgery as effective open surgery for nasal cancer 2Health News:Celebrity Permanent Makeup Artist Slams Claim "Michael Jackson Didn't Want to be Black" 2Health News:Celebrity Permanent Makeup Artist Slams Claim "Michael Jackson Didn't Want to be Black" 3Health News:Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company 2
... Diagnostics iQ®200 Automated Urine Microscopy Analyzer ... Recognition (APR®) software to classify urine ... report results. The iQ200 eliminates most ... interpret particle images by automating specimen ...
... The ISOPLATER® is an automatic ... load, streak and stack up to ... hour. Automated streaking results in substantial ... productivity, improves isolation rates, standardizes streaking ...
... a brand-new high technology state-of-the-art system offering ... and ease-of-use for every user. The flexible ... basic investigations as well as research purposes. ... This allows you to obtain the functionality ...
... Delphis™ is ideal for any clinical ... to performing a UDS procedure. Customize ... the options of a Pocket PC, ... Delphis with Bluetooth™ wireless technology allows ...
Medicine Products: